Klin Monbl Augenheilkd 2019; 236(04): 581-583
DOI: 10.1055/a-0829-6036
Der interessante Fall
Georg Thieme Verlag KG Stuttgart · New York

Uveitis-Glaucoma-Hyphema Syndrome Treated with Haptic Amputation

Uveitis-Glaucoma-Hyphema-Syndrom behandelt durch Haptic Amputation
Mohamad El Wardani
1   Department of Ophthalmology, University of Lausanne, Hôpital Ophtalmique Jules-Gonin, Lausanne, Switzerland
,
Georgios Kymionis
1   Department of Ophthalmology, University of Lausanne, Hôpital Ophtalmique Jules-Gonin, Lausanne, Switzerland
2   1st Department of Ophthalmology, G. Gennimatas Hospital, Athens, Greece
,
Basile Salmon
1   Department of Ophthalmology, University of Lausanne, Hôpital Ophtalmique Jules-Gonin, Lausanne, Switzerland
,
Kattayoon Hashemi
1   Department of Ophthalmology, University of Lausanne, Hôpital Ophtalmique Jules-Gonin, Lausanne, Switzerland
,
Thomas J. Wolfensberger
1   Department of Ophthalmology, University of Lausanne, Hôpital Ophtalmique Jules-Gonin, Lausanne, Switzerland
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 19. September 2018

accepted 18. Dezember 2018

Publikationsdatum:
27. Februar 2019 (online)

Preview

Introduction

Uveitis-glaucoma-hyphema syndrome, or UGH syndrome, is caused by friction between an artificial intraocular lens (IOL) and the iris or ciliary body [1]. Both anterior and, to a lesser extent, posterior IOLs, especially sulcus implanted lenses, have been associated with UGH syndrome [2]. A possible mechanism to explain this syndrome is the chronic chaffing of the iris or ciliary body that causes a breach in the blood aqueous barrier, eventually leading to an intraocular inflammation and even full-blown uveitis. Hemorrhage is the result of intermittent vessel injury. Glaucoma could result as a reaction to direct injury of the trabecular meshwork in case of anterior chamber IOL or secondary to uveitis, hyphema, and pigment dispersion.

The management of UGH syndrome depends on the severity of the situation. In mild to moderate cases, conservative treatment with a combination of anti-inflammatory and anti-glaucoma medications may be sufficient. In selected cases, laser iridotomy may be beneficial. In more advanced situations, surgical management is necessary, usually with a complete IOL exchange [3], [4], [5].

In this article, we present a case of haptic-induced UGH syndrome, which was successfully managed by an isolated intraoperative IOL haptic amputation.